#Genetic tools for coronary risk assessment in type 2 #diabetes: A cohort study from the ACCORD #clinical #trial. https://t.co/7A8MVsXIv2
Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial. https://t.co/EDdaCK3xsl https://t.co/YzLmfq7OEl
RT @RevistaMFSamfyc: Herramientas genéticas para valoración del riesgo coronario en la diabetes tipo 2: estudio de cohorte procedente del e…
Herramientas genéticas para valoración del riesgo coronario en la diabetes tipo 2: estudio de cohorte procedente del ensayo clínico ACCORD https://t.co/nqdP0pQszq PMID 30262460
Genetic Tools for Coronary Risk Assessment in Type 2 #Diabetes: A Cohort Study From the ACCORD Clinical Trial https://t.co/3F0Tskn7gd
RT @mbotana: Datos a partir del ACCORD: el "score" genético para cardiopatía isquémica aplicable a la población general también es aplicabl…
RT @mbotana: Datos a partir del ACCORD: el "score" genético para cardiopatía isquémica aplicable a la población general también es aplicabl…
RT @mbotana: Datos a partir del ACCORD: el "score" genético para cardiopatía isquémica aplicable a la población general también es aplicabl…
RT @mbotana: Datos a partir del ACCORD: el "score" genético para cardiopatía isquémica aplicable a la población general también es aplicabl…
RT @mbotana: Datos a partir del ACCORD: el "score" genético para cardiopatía isquémica aplicable a la población general también es aplicabl…
Datos a partir del ACCORD: el "score" genético para cardiopatía isquémica aplicable a la población general también es aplicable para los pacientes con #diabetes 2: Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes... https://t.co/NDXS5zFzTQ
Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial https://t.co/giuTwhWab9
RT @HarvardEpi: Publication: Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial h…
Publication: Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial https://t.co/p1GTWdOaan
RT @pnatarajanmd: In the ACCORD and ORIGIN clinical trials, a CAD polygenic risk score associated with major adverse cardiovascular events…
RT @pnatarajanmd: In the ACCORD and ORIGIN clinical trials, a CAD polygenic risk score associated with major adverse cardiovascular events…
In the ACCORD and ORIGIN clinical trials, a CAD polygenic risk score associated with major adverse cardiovascular events (HR 1.27 and 1.35 per score SD, respectively) https://t.co/dM8TQ5BP9R @AmDiabetesAssn
Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial https://t.co/JM728YROaO
A study in #Diabetes Care showed that genetic risk scores can be used to predict the risk of developing #CoronaryArteryDisease among patients with #Type2Diabetes before signs such as increased cholesterol levels and weight gain appear https://t.co/6lPbpXqM
Marcadores geneticos que pueden predecir la evolucion a #CAD en pacientes con #Diabetes. Via @ADA_Journals https://t.co/jqT5WRaPRU https://t.co/czOjyFH2Hz
RT @ADA_Journals: A cohort study from the #ACCORD Clinical Trial finds genetic markers that could be used to predict the risk of major #CAD…
Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial. https://t.co/4KuwQAeIwQ https://t.co/cmTdz8ysB5
Coronary Risk Assessment in Type 2 #Diabetes Beyond Risk Factors-Performance of a GRS in ACCORD and ORIGIN https://t.co/EjU5tAF0bB
RT @ADA_Journals: A cohort study from the #ACCORD Clinical Trial finds genetic markers that could be used to predict the risk of major #CAD…
A cohort study from the #ACCORD Clinical Trial finds genetic markers that could be used to predict the risk of major #CAD events among patients with #T2D. https://t.co/zGj4uGQKkg https://t.co/ZvhR3JJr6z